FDA Clears New Menopause Drug

The non-hormonal treatment was found to significantly reduce hot flashes and night sweats associated with menopause.

Ap
AP

According to a recent USA Today article, the FDA has approved Veozah, a drug developed by Astellas Pharma, to treat menopause symptoms. Veozah is a once-a-day pill that has been found to significantly reduce hot flashes and night sweats associated with menopause by blocking a chemical called neurokinin B (NKB) in the brain, which regulates body temperature. This drug is intended to replace traditional hormonal therapies that aren’t suitable for all patients, especially those with certain health conditions.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO